Clinical trials
Epigenetics clinical trials
Below are recruiting epigenetics clinical trials, each written for real people, not researchers. We’re tracking 62 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06022328Recruiting
Epigenetic age and prognosis in blood cancers
This study looks at how 'epigenetic age' (a measure of certain changes in your DNA) relates to the way blood cancers called myeloproliferative neoplasms (MPNs) develop and progress. It may help doctors better understand and predict the course of these diseases.
BordeauxAges 18 years+ - NCT06098495Recruiting
Blood test to predict female infertility
This trial looks for a blood test that could help predict infertility in women. If you are between 18 and 43, struggling with infertility or recurrent pregnancy loss, this study may be a fit.
MilanAges 18–43 - NCT07764380Recruiting
Stress during pregnancy and its effects on mothers and babies
This study looks at how stress during pregnancy might affect stress hormones and genes in pregnant women. It aims to understand these effects to better support mothers and babies.
KahramanmaraşAges 18–49 - NCT07436195Recruiting
Epigenetics and cell-free DNA in gestational diabetes study
This study looks at how changes in DNA (called epigenetics) might affect gestational diabetes in pregnancy. It aims to understand these changes using cell-free DNA from the mother and father.
Ulm, Baden-WurttembergAges 18 years+ - NCT07250217Recruiting
Study of AML epigenetic markers in older adults
This trial looks at certain chemical changes in blood cells of two groups of people aged 60 or older: those having heart surgery (control group) and those with a type of blood cancer called acute myeloid leukemia (AML) who will be treated with a drug called azacitidine. The goal is to find markers that could help personalize treatment for AML in seniors.
Mulhouse, AlsaceAges 60 years+ - NCT07008664Recruiting
DNA test for lung cancer diagnosis
This study is testing a new blood test to help diagnose lung cancer by looking at certain markers in your DNA. Researchers want to see if this test can accurately find lung cancer, which could lead to earlier detection.
Glen Burnie, MarylandAges 18 years+ - NCT06888102RecruitingEarly Phase 1
Epigenetic therapy before prostate surgery
This trial tests a short course of 'epigenetic therapy' (drugs that change how genes work) given before prostate removal surgery. The goal is to see if it can improve treatment effects and help shrink or control the tumor.
Los Angeles, CaliforniaAges 18 years+ - NCT05791149Recruiting
Saliva test to help diagnose oral cavity cancer
This study looks for changes in saliva (epigenetic biomarkers) that may help doctors diagnose squamous cell carcinoma in the mouth. You may be asked for saliva samples and usual clinical checks to see whether the test can help with diagnosis, especially before surgery.
Amiens, PicardieAges 18 years+ - NCT04714957Recruiting
Personalized study for cancer spread in the belly lining
This trial studies people whose cancer has spread to the lining of the abdomen (the “belly lining”), including cancers from the digestive tract or ovaries. You may be asked to join because the study aims to learn how to better match care to different patterns of this belly lining cancer spread.
LyonAges 18 years+ - NCT03855657Recruiting
Biobank study of gut microbes, genes, and blood chemistry
This study collects samples to learn how gut microbes, genetics, and body chemistry may relate to Crohn’s disease or ulcerative colitis. Your information and samples may help researchers understand disease patterns, but it does not test a new drug.
Hong KongAges 18 years+ - NCT05767216Recruiting
Study of genetic and epigenetic differences in twin pairs with Down syndrome
This study looks at how genetics and gene-regulation (how genes turn on and off) differ between close family members who have different Down syndrome status. Researchers hope the findings will help explain why Down syndrome outcomes can vary even in very closely related people.
ParisAges 4–11 - NCT05963451Recruiting
Testing treatments for long-term low back pain from facet joints
This study focuses on people with long-lasting low back pain that likely comes from the small “facet” joints in the lower spine. It aims to better understand brain, psychological, and biology changes to help optimize treatment for this type of back pain.
Sherbrooke, QuebecAges 18–75 - NCT03742011Recruiting
Study of babies born to mothers with PCOS in Guangzhou
This study looks at children born to mothers who have polycystic ovary syndrome (PCOS). It aims to learn about their health by following families in Guangzhou over time.
Guangzhou, GuangdongAges Up to 18 years - NCT06305091Recruiting
DNA Changes in Veterans Exposed to Burn Pits
This study looks for DNA changes in veterans who were exposed to open burn pits during deployment. It aims to understand health risks from these exposures.
North Little Rock, ArkansasAges 25–70 - NCT06372054Recruiting
Predicting health risks for Italian Air Force members
This study aims to develop smart risk models using your body's data (like proteins and genes) along with personal exposure readings. It will help predict health risks for Italian Air Force personnel. You will wear a monitor and give samples, then be followed over time.
MilanAges 26–38 - NCT06373822Recruiting
Understanding adenomyosis through genetics
This trial studies genetic factors (epigenetics and miRNAs) to understand why adenomyosis develops. By comparing tissue samples, researchers hope to find new ways to diagnose or treat this condition.
Brussels, Woluwe-Saint-LambertAges 18 years+ - NCT04814407Recruiting
Test blood and other markers to detect early lung cancer
This study looks for new “epigenetic” signals in blood (signals about how genes are turned on/off) to help detect lung cancer early. You might be able to join if you are being evaluated for possible lung cancer or have small, unclear spots on a lung CT scan.
TaipeiAges 20 years+ - NCT07814235Recruiting
Freezing sperm as a way to protect quality as men age
This study is looking at whether freezing sperm can protect the quality of sperm as men age. If you join, you'll provide samples for research, and the findings could help men plan for future fertility.
Murcia, MurciaAges 18–65 - NCT07738003Recruiting
Perinatal Autism Genetics and Epigenetics Study
This study looks at genetics and other factors that may be linked to autism. Pregnant women in their first or second trimester are invited to join, and their babies will be followed to see how they develop.
Iowa City, IowaAges birth–50 years - NCT07707778Enrolling by invitationPhase 4
Tirzepatide for Weight and Aging in People with HIV
This trial tests whether a weight-loss medicine called tirzepatide can slow biological aging and improve metabolism in people with HIV who are already on effective treatment. It may help you reduce weight and possibly reverse some signs of aging.
TaipeiAges 18 years+ - NCT06690866Recruiting
Emotions and genetics during puberty in girls
This study looks at how emotions and genetics change during puberty in healthy girls. It involves questionnaires, interviews, and possibly an MRI scan to understand these changes.
Tübingen, Baden-WurttembergAges 8–17 - NCT07631624Recruiting
Blood test for lung cancer screening in smokers and former smokers
This study tests whether a simple blood test that detects smoking-related changes in DNA can help identify who should get lung cancer screening. Researchers want to see if this test is better at finding people at risk than current methods.
Antwerp, AntwerpenAges 50 years+ - NCT06706687Recruiting
Brain imaging and epigenetics in frontotemporal dementia and bipolar disorder
This study uses brain scans and genetic tests to understand the differences between behavioral variant frontotemporal dementia (bvFTD) and bipolar disorder. It may help improve diagnosis and find better treatments for both conditions.
Milan, MIAges 18 years+ - NCT06706973Recruiting
Epigenetic study for new head and neck cancer treatments
This trial studies the role of epigenetic marks in head and neck cancer to improve diagnosis and treatment. If you have been newly diagnosed with head and neck squamous cell carcinoma and have not yet received treatment, you may be eligible to participate.
Milan, MIAges 18 years+
Hear when a new Epigenetics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for epigenetics?
- Yes. Clin2 currently lists 62 recruiting epigenetics studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a epigenetics trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a epigenetics trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.